Recent Trends and Patient Outcomes of Phase I Trials: A Single-Institution Experience in the Era of New Therapeutic Agents This study reviewed all industry-sponsored phase I clinical trial protocols ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The project will transport more ...
In a recent exclusive interview, Fierce Biotech’s Chris Hayden sat down with Alex MacDonald, Vice President of Model-Informed Drug Development at Allucent, to explore the impact of Project Optimus, an ...
Time-Cost Trade-Off optimisation in project scheduling is a pivotal aspect of contemporary project management and operations research. It involves the formulation and application of both classical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results